跳至主要内容
临床试验/NCT07021729
NCT07021729尚未招募4 期

Comparison of Conventional Clarithromycin Vs Alternative Levofloxacin Based Regimen in Treatment of Helicobacter Pylori Infection

Rehman Medical Institute - RMI0 个研究点目标入组 156 人开始时间: 2025年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
156
主要终点
Treatment of H pylori infection

研究概览

简要总结

The goal of this interventional study is to compare the efficacy of clarithromycin Vs levofloxacin based regimen in treatment of Helicobacter pylori infection in patients presenting to medical OPD who are tested positive for H pylori infection.. The main question[s] it aims to answer are:

• Which regimen is superior in terms of efficacy Participants will be treated for H pylori Infection in with two different regimen If there is a comparison group: Researchers will compare two groups Group 1 will receive clarithromycin based regimen group 2 will receive levofloxacin based regimen to see the treatment response.

详细描述

This interventional study will be conducted in department of medicine, Rehman Medical Institute, Peshawar.

Study duration: 10 months after the issuance of ethical approval Sample size: Sample size is calculated using a two-tailed alpha test with a significance level of 0.05 and 90% power to detect 23% difference in the eradication rate of the two regimens. The total number of patients required to prove the hypothesis is 156, 78 in each group.

Study population: Patients coming to OPD with symptoms suggestive of H pylori infection will undergo screening by Hpylori stool antigen. If it comes to be positive then they will be enrolled in study after applying inclusion/exclusion criteria.

Inclusion criteria: All patients who tested positive on stool antigen will be included. Age >12 years and both genders will be included.

Exclusion criteria: patients under 12 years old. Patients who have penicillin allergy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients who tested positive on stool antigen will be included.

排除标准

  • patients under 12 years old. Patients who have penicillin allergy.
  • Patients who have underlying dysrhythmia forbidding the use of macrolide.
  • Patient who have hypersensitivity to any of these antibiotics.

研究组 & 干预措施

Regime 1

Active Comparator

This arm will receive clarithromycin based regimen for eradication of H pylori infection (as per approved guidelines)

干预措施: Clarithromycin (Drug)

Regime 2

Active Comparator

This arm will receive levofloxacin based regimen for eradication of H pylori infection (as per approved guidelines)

干预措施: Levofloxacin (Drug)

结局指标

主要结局

Treatment of H pylori infection

时间窗: 2weeks after completion of treatment regimen

Treatment of H pylori infection documented by negative stool antigen

次要结局

未报告次要终点

研究者

发起方
Rehman Medical Institute - RMI
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wajeeha Qayyum

Consultant/Assistant Professor Medicine

Rehman Medical Institute - RMI

相似试验